IN VITRO MODEL OF THE BLOOD-BRAIN BARRIER

Information

  • Research Project
  • 3507948
  • ApplicationId
    3507948
  • Core Project Number
    R44GM042268
  • Full Project Number
    2R44GM042268-02
  • Serial Number
    42268
  • FOA Number
  • Sub Project Id
  • Project Start Date
    3/17/1989 - 35 years ago
  • Project End Date
    6/30/1992 - 32 years ago
  • Program Officer Name
  • Budget Start Date
    7/15/1990 - 34 years ago
  • Budget End Date
    6/30/1991 - 33 years ago
  • Fiscal Year
    1990
  • Support Year
    2
  • Suffix
  • Award Notice Date
    7/11/1990 - 34 years ago

IN VITRO MODEL OF THE BLOOD-BRAIN BARRIER

In the coming years, the treatment of neurological disorders will be largely dependent on the development of new therapeutic agents and the modification of those compounds already in existence. The blood-brain barrier keeps most drugs out of the brain and severely limits their usefulness. Pharmaceutical companies will, therefore, need to screen many compounds for their entry into the brain and will also have to consider a variety of strategies designed to overcome the blood-brain barrier. Currently, compounds are screened by injecting them into large numbers of animals and either observing indirect and cumbersome and also raise important animal welfare concerns. A cell culture model of the blood-brain barrier would both facilitate rapid screening for compounds able to enter the brain and would also allow the systematic use of cell and molecular biological to enter the brain and would also allow the systematic use of cell and molecular biological techniques to develop drug delivery systems. In this proposal, we describe a technique for growing brain endothelial cells such that they form, the cell culture, an equivalent of the blood- brain barrier. We detail a set of experiments that will enable this model system to be used routinely by groups interested in nervous system therapeutics. We also describe ways in which this model system can be utilized to explore novel modes of drug delivery to the brain.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R44
  • Administering IC
    GM
  • Application Type
    2
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    821
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    PSF
  • Study Section Name
    Physiological Sciences Study Section
  • Organization Name
    ATHENA NEUROSCIENCES, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    SOUTH SAN FRANCISCO
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    94080
  • Organization District
    UNITED STATES